CDD for Biologics Summit on October 22-24, 2024 in Boston, United States

Welcome to the 9th CDD for Biologics Summit

For the past eight years, the CDD for Biologics Summit has united computational and structural biologists, along with protein and antibody engineers, to showcase emerging computational programs and models aimed at revolutionizing biologics drug discovery and development.

With the transformative impact of AI-driven approaches in enhancing predictability, optimizing molecular design, and mitigating inherent risks in drug development pipelines, the summit is an indispensable platform for industry leaders to collaborate, innovate, and propel drug discovery forward amidst this era of computational excellence.

The 9th annual event returns to Boston in 2024, continuing to support drug developers of all sizes in advancing their novel biotherapeutics discovery and development. Join us to dive into the latest industry innovations, highlighting methods and best practices to automate and streamline data collection, integrate experimental data, and leverage state-of-the-art deep learning models for the progression of novel, complex biologics pipelines.

URLs:

Tickets: https://go.evvnt.com/2514984-2?pid=10008

Brochure: https://go.evvnt.com/2514984-3?pid=10008

Time: 9:00 AM - 5:00 PM

Prices:

Drug developer pricing - Conference + Workshop Day: USD 4197.00,

Academic pricing - Conference + Workshop Day: USD 3597.00,

Solution Providers pricing - Conference + Workshop Day: USD 5097.00,

Drug developer pricing - Conference Only: USD 2999.00,

Academic pricing - Conference Only: USD 2599.00,

Solution Providers pricing - Conference Only: USD 3699.00

Speakers: Amir Shanehsazzadeh | Senior AI Scientist | AbSci, Christopher Negron | Principal Scientist - Research | Abbvie, Goutham Mylavarapu | Associate Director | Teva Pharmaceuticals USA, Inc., James Bowman | Investigator, Director of Protein Engineering | AI Proteins, Johannes Loeffler | Postdoctoral Researcher | The Scripps Research Institute, Kyle Barlow |Senior Scientist | Adimab LLC, Linna An | Postdoctoral Research | Institute for Protein Design, Mark Aquino | Associate Director and Principal Data Scientist | Abbvie, Maryam Pouryahya |Associate Director - Data Science | AstraZeneca, Michael Marlow |Director of Biologics, Chemistry, Manufacturing and Controls Research | Boehringer Ingelheim, Naresh Chennamsetty | Associate Scientific Director | Bristol Myers Squibb, Peixin Zhu | Vice President - Editing Discovery | Verve Therapeutics, Philip Kim | Professor | University of Toronto, Prashanth Vishwanath | Director and Head Of Biologics Informatics and Automation | Takeda Pharmaceutical Co. Ltd., Randolph Lopez | Chief Technology Officer | A-Alpha Bio Inc., Varun Chauhan | Research Scientist | Elanco, Yao Fan | Director - Protein Design and Optimization | Tectonic Therapeutic, Yifan Song | Chief Science Officer and Co-Founder | Cyrus Biotechnology Inc, Zhiyong Xie | Vice President and Head of AI and Data Science | Xellar Biosystems